Biosocieties

Papers
(The TQCC of Biosocieties is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Publisher Correction: Citizenship in times of crisis: biosocial state–citizen relations during COVID-19 in Austria15
Sexual health as surplus: the marketization of PrEP in Taiwan13
Conceptualization of genotype–phenotype relationships and the assessment of risk in advertising of direct-to-consumer and preimplantation polygenic tests12
When sociality fails to produce solidarity: environmental NGOs and the politics of public engagement in contemporary China12
“Black race”, “Schwarze Hautfarbe”, “Origine africaine”, or “Etnia nera”? The absent presence of race in European pharmaceutical regulation11
Cell freezing and the biology of inexorability: on cryoprotectants and chemical time11
Discipline for pleasure: a new governmentality of HIV prevention10
Mapping ‘bio geo-body’ of Southeast Asia: strategic differentiation and identification of ethnic identity in Vietnam and Singapore10
“An entire career in 10 seconds”: on protein chemistry, AI, and the threat of obsolescence10
Hormonal stories: a new materialist exploration of hormonal emplotment in four case studies8
Adjusting the analytical aperture: propositions for an integrated approach to the social study of reproductive technologies8
Bleak Biopolitics and Abolitionist Aspirations: Recent Books on Race7
Agri-food tech’s building block: narrating protein, agnostic of source, in the face of crisis7
Post-identifiability in changing sociotechnological genomic data environments7
What to do with the new molecular publics: the vernacularization of pathogen genomics and the future of infectious disease biosocialities7
Epistemology of the side effect: anecdote and evidence in the digital age6
Accept no limits: biocontainment and the construction of a safer space for experimentation in xenobiology as a legacy of Asilomar6
Challenges in public policy for the implementation of pharmacogenetic tests in Europe6
Openness in donor conception families5
Introduction to the special issue: Politics of suspension? Time, space, and control in cryopreservation practices5
Ectogenesis, inequality, and coercion: a reproductive justice-informed analysis of the impact of artificial wombs5
Making death through producing life: Necrovalue and the political economy of death5
It’s all about kids, kids, kids! Negotiating reproductive citizenship and patient-centred care in ‘factory IVF’4
Negotiating the necessity of biomedical animal use through relations with vulnerability4
Correction to: The other face of medical globalization? Pharmaceutical data, prescribing trends, and the social localization of psychostimulants4
Psychedelic innovations and the crisis of psychopharmacology4
Styles of thought in healthcare governance: A situational analysis of English PrEP discourse 2016–20204
Value-creation in the health data domain: a typology of what health data help us do4
Our thanks to founding editor Professor Nikolas Rose4
Beyond controversies in child mental health: negotiating autism and ADHD diagnosis in France and Brazil4
Correction: An imagined future community: Taiwan Biobank, Taiwanese genome, and nation-building4
0.03228497505188